Simvastatin and Rifaximin as new therapy for patients with decompensated cirrhosis

Responsabile scientifico: prof. Caraceni Paolo

Ente finanziatore: COMMISSIONE EUROPEA

Durata: 01/01/2017 - 31/12/2021